MMRC Horizon One: A Phase II Randomized adaptive platform Trial evaluating novel therapies in relapsed or refractory multiple myeloma Read more
Real world experience with KCD-R management in patients with newly diagnosed Waldenstrom Macroglobulinemia Read more
Clinical Grade Molecular Profiling of Patients with Multiple Myeloma and Related Plasma Cell malignancies Read more
A Phase 2 Study of Erdafitinib in Patients with Recurrent or Progressive IDH-Wild Type Glioma with an FGFR-TACC Gene Fusion Read more
Characteristics and Outcomes of Patients with Multiple Myeloma Treated with Chimeric Antigen Receptor T Cell Therapy” Read more
Prognostic significance of cytogenetic abnormalities and molecular classification on mortality and morbidity at Hackensack Meridian Health in patients treated for multiple myeloma Read more
Comparative Analysis of Osteonecrosis of the Jaw Incidence in Multiple Myeloma Patients Treated with Denosumab vs. Bisphosphonates: A Retrospective Cohort Study Read more
